The Bill & Melinda Gates foundation has awarded EPFL-based foundation iM4TB $2.45 million to take their innovative anti-tuberculosis drug PBTZ169 into clinical trials.
April 25, 2017 at 11:30AM
from Startupticker
Featured Post
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment